Response to comment on "Evaluation of the safety and tolerability of intravenous undiluted levetiracetam at a pediatric institution".

IF 2.9 3区医学 Q2 PHARMACOLOGY & PHARMACY

Pharmacotherapy Pub Date : 2024-05-01 DOI:10.1002/phar.2919

Lily Price, Lisa Garrity, Sarah Stiehl

引用次数: 0

查看原文本刊更多论文

对 "一家儿科机构对静脉注射未稀释左乙拉西坦安全性和耐受性的评估 "评论的回复。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Pharmacotherapy 医学-药学

CiteScore

7.80

自引率

2.40%

发文量

审稿时长

4-8 weeks

期刊介绍： Pharmacotherapy is devoted to publication of original research articles on all aspects of human pharmacology and review articles on drugs and drug therapy. The Editors and Editorial Board invite original research reports on pharmacokinetic, bioavailability, and drug interaction studies, clinical trials, investigations of specific pharmacological properties of drugs, and related topics.